125 related articles for article (PubMed ID: 34525842)
1. Off-label antipsychotic use patterns among Texas Medicaid adults 2013-2016.
Chen S; Barner JC; Cho E
J Comp Eff Res; 2021 Oct; 10(14):1045-1053. PubMed ID: 34525842
[No Abstract] [Full Text] [Related]
2. Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016.
Chen S; Barner JC; Cho E
J Manag Care Spec Pharm; 2021 Aug; 27(8):1035-1045. PubMed ID: 34337993
[No Abstract] [Full Text] [Related]
3. Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.
Hartung DM; Middleton L; McFarland BH; Haxby DG; McDonagh MS; McConnell KJ
Psychiatr Serv; 2013 Dec; 64(12):1236-42. PubMed ID: 23999754
[TBL] [Abstract][Full Text] [Related]
4. Off-label use of antipsychotic medications in Medicaid.
Leslie DL; Rosenheck R
Am J Manag Care; 2012 Mar; 18(3):e109-17. PubMed ID: 22435962
[TBL] [Abstract][Full Text] [Related]
5. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
Kamble P; Sherer J; Chen H; Aparasu R
Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
[TBL] [Abstract][Full Text] [Related]
6. Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses.
Højlund M; Andersen JH; Andersen K; Correll CU; Hallas J
Epidemiol Psychiatr Sci; 2021 Apr; 30():e28. PubMed ID: 33820580
[TBL] [Abstract][Full Text] [Related]
7. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
[TBL] [Abstract][Full Text] [Related]
8. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
Leslie DL; Mohamed S; Rosenheck RA
Psychiatr Serv; 2009 Sep; 60(9):1175-81. PubMed ID: 19723731
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults.
Horvitz-Lennon M; Volya R; Hollands S; Zelevinsky K; Mulcahy A; Donohue JM; Normand ST
Psychiatr Serv; 2021 Sep; 72(9):1031-1039. PubMed ID: 34074139
[TBL] [Abstract][Full Text] [Related]
10. Diagnoses and antipsychotic treatment among youths in a public mental health system.
Patel NC; Crismon ML; Shafer A
Ann Pharmacother; 2006 Feb; 40(2):205-11. PubMed ID: 16434563
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA.
Zhu X; Hu J; Sun B; Deng S; Wen Y; Chen W; Qiu C; Shang D; Zhang M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):216-224. PubMed ID: 29336603
[TBL] [Abstract][Full Text] [Related]
12. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
[TBL] [Abstract][Full Text] [Related]
13. Incident users of antipsychotics: who are they and how do they fare?
Baandrup L; Kruse M
Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887
[TBL] [Abstract][Full Text] [Related]
14. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Pathak P; West D; Martin BC; Helm ME; Henderson C
Psychiatr Serv; 2010 Feb; 61(2):123-9. PubMed ID: 20123816
[TBL] [Abstract][Full Text] [Related]
16. Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.
Lao KSJ; Tam AWY; Wong ICK; Besag FMC; Man KKC; Chui CSL; Chan EW
Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1387-1394. PubMed ID: 28665012
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.
Painter JT; Owen R; Henderson KL; Bauer MS; Mittal D; Hudson TJ
Pharmacotherapy; 2017 Apr; 37(4):438-446. PubMed ID: 28164355
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.
Park Y; Huybrechts KF; Cohen JM; Bateman BT; Desai RJ; Patorno E; Mogun H; Cohen LS; Hernandez-Diaz S
Psychiatr Serv; 2017 Nov; 68(11):1112-1119. PubMed ID: 28617210
[TBL] [Abstract][Full Text] [Related]
19. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
Pennap D; Burcu M; Safer DJ; Zito JM
Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557
[TBL] [Abstract][Full Text] [Related]
20. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.
Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM
J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
